In the News

Digital health startup Xealth has raised $11 million in a series A financing round and has attracted investment from a who's who of investors including Novartis, a digital therapeutics company,…

While healthcare is notorious for being a industry that resists change, or for being one that at least changes slowly. There's good reason for this, of course, not least of…

Providence St. Joseph Health's spinout Xealth pulled in an $11 million Series A financing round to fuel expansion. The round was lead by California-based McKesson Ventures, the Swiss pharmaceutical company…

McKesson Ventures, Novartis, Philips, ResMed join Threshold Ventures, the Froedtert & MCW Health Network, Providence Ventures, UPMC to accelerate Xealth's digital health prescribing platform.

The Providence-St. Joseph Health spinoff's platform allows clinicians to prescribe apps and other digital tools to patients through their normal EHR workflow.

The Series A funding came from a slew of investors, including Novartis, Philips, McKesson Ventures, ResMed, Providence Ventures and UPMC.

Xealth, a Seattle-based digital prescribing platform has raised $11 million in Series A funding from McKesson Ventures, Novartis, Philips, and ResMed. Existing investors Threshold Ventures (formerly DFJ Venture), Providence Ventures,…

Is there big market for prescriptions beyond drugs? Several investors with deep experience in health are betting on it — joining in a new $11 million funding round for Xealth,…

Xealth, the leading digital prescribing platform, today announced that it has raised $11 million in a Series A financing round, with new investment from health care industry leaders and investors…

True to their word, the company spun out in 2017. And today, Xealth announced an $11 million Series A to fuel further growth, with backing from a list of investors…